Company Focus - eGenesis Bio 致力于将利用动物作为器官来源的愿景变为现实 [1] - eGenesis Bio 总裁兼 CEO Mike Curtis 在 ForbesHealth Summit 上讨论了改变器官移植体验 [1]

Investor Day November 2025 Agenda Slide | 1 | Business Overview & Key Investment Highlights | | --- | --- | | 2 | How Organ Transplantation Works | | 3 | Logistics Services | | 4 | Organ Recovery Clinical Services | | 5 | Organ Placement Services | | 6 | Cardiac Care Clinical Services | | 7 | Regulatory Update | | 8 | Technology | | 9 | Unit Economics & Contract Structure | | 10 | Financial Performance and Outlook | | 11 | Q&A 2 | FORWARD LOOKING STATEMENTS This presentation contains "forward-looking statem ...

Healthcare Industry Need - Less than 10% of people worldwide in need of organ transplants receive them [1] - Pigs, due to their ease of breeding and appropriately sized organs, present a potential solution to the organ shortage [1]

Acquisition - Terumo agreed to acquire OrganOx, a UK-based organ medical tech company [1] - The deal is valued at approximately $1.5 billion [1] Strategic Focus - Terumo aims to enter the organ transplant field through this acquisition [1]